PROCESSA PHARMACEUTICALS INC
Q1 2026 13F Holders
Symbol
PCSA
CUSIP
74275C403
Type
Equity
Class
COM SHS
Num filings
10
Total reported value, excl. options
$448 k
Compare 2026 Q1 to
2026 Q2
2025 Q4
Manager
Report Date
Value ($000)
Shares
Option Type